On October 27, the website of the State Food and Drug Administration issued the "Announcement of the State Food and Drug Administration on the Revision of the Instructions for Domperidone Preparation", in which the "precautions" required for the revision of the prescription instr

2025/07/0516:29:38 regimen 1627

bloating, stomachache , stomach discomfort...

Common over-the-counter medicines in the home medicine box

For example, digestive-promoting

must have an impression of you?

"Handle pain, stomach bloating, use morbidine "

"Handle pain in digestion, find morbidine help"

morbidine

This is a common medicine called digestion and treatment of stomach pain

Domperidone

is a regular drug in many families.

Recently, it was once again asked to revise the instructions

On October 27, the website of the National Medical Products Administration issued the "Announcement of the National Medical Products Administration on Revising the instructions for Domperidone Preparation (No. 93 of 2022)", among which, the revision of the prescription instructions for domperidone preparations requires "precautions" to include: children under 12 years old (especially infants), adolescents weighing less than 35 kg and adults, and closely monitor adverse reactions when taking the medicine.

Domperidone preparation Over-the-counter drug instructions revision requirements "Precautions" should include: This product is not suitable for children under 12 years old (especially infants), adolescents and adults weighing less than 35 kg.

On October 27, the website of the State Food and Drug Administration issued the

Domperidone is a gastrointestinal promoter

There are many domestic companies producing

In the past two years,

Domperidone represented by morphine

The application of in clinical practice is becoming more and more stringent

October 28

Deputy Director of the Pharmacy Department of Beijing Hospital Zhang Yatong

Tell Health Times reporter

" Not any patient can use

Only after passing the evaluation under certain conditions will it be used

Now the overall dose of this drug in each hospital is slowly decreasing

It can be said that

mortaline has been from the original common medicine

becomes a drug that is fully evaluated and then used reasonably.

announced that according to the results of the adverse drug reaction evaluation, in order to further ensure the safety of public drug use, the State Food and Drug Administration decided to uniformly revise the instructions for domperidone preparations (including domperidone tablets, domperidone dispersed tablets, domperidone oral disintegration tablets, domperidone capsules, domperidone suspension, domperidone maleate tablets)

As early as August 2016, the Health Times reported that in 2015, the Canadian Ministry of Health even affirmed the risk correlation, saying that domperidone would slightly increase the risk of severe ventricular arrhythmia or sudden cardiac death. Health Canada recommends that medication should be taken at the smallest dose possible in the beginning. In April 2014, the European Medicines Agency published a report recommending that it limit its indications within the entire EU range, and only to relieve nausea and vomiting symptoms, and no longer be used to treat other indications such as bloating or heartburn.

In September 2016, the former State Food and Drug Administration issued the "Announcement on Revising the Instructions for Domperidone Preparation", which revised the instructions for Domperidone over-the-counter and prescription drugs. In the adverse reactions, the content related to heart disease has also been added.

On October 27, the website of the State Food and Drug Administration issued the

"Dopestidone can be said to be an old drug. This time, it was re-emphasized after re-emphasis. Previously, many clinical evaluations have found that there are risks in children's use, and children should be cautious when using domperidone. This time, the prescription and over-the-counter drugs of morphine have been revised to varying degrees. Over-the-counter drugs limit children to improve the clinical safe use." Zhang Yatong explained that previously FDA pointed out that the serious adverse reactions of domperidone include arrhythmia , cardiac arrest, and sudden death of .

The marketing authorization holders of the above-mentioned drugs shall submit the Drug Review Center of the State Drug Administration or the provincial drug supervision and administration department before January 24, 2023 in accordance with the relevant regulations of the " Drug Registration Management Measures " and other relevant regulations, and in accordance with the revision requirements of domperidone preparations. Drugs produced from the date of filing shall not continue to be used in the original drug instructions.

Remember:

Drugs are drugs after all

is a medicine three-part poison

None of the drugs are suitable for overdose

None of the drugs are suitable for overdose

If the condition has not improved after taking the medicine

Don't delay it. Go to the hospital in time to seek medical treatment

to avoid delaying the disease

Follow the doctor's advice and take medicine symptomatically is the key

regimen Category Latest News